000 01644 a2200421 4500
005 20250516060609.0
264 0 _c20120809
008 201208s 0 0 spa d
022 _a1578-8989
024 7 _a10.1016/j.medcli.2011.07.014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _ade la Haba-Rodríguez, Juan R
245 0 0 _a[ABCB1 polymorphisms in patients with Charcot-Marie-Tooth disease. A possible relationship with neurotoxicity due to cytostatic treatment].
_h[electronic resource]
260 _bMedicina clinica
_cApr 2012
300 _a456-7 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAdenocarcinoma
_xcomplications
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aBreast Neoplasms
_xcomplications
650 0 4 _aCharcot-Marie-Tooth Disease
_xcomplications
650 0 4 _aColonic Neoplasms
_xcomplications
650 0 4 _aCytostatic Agents
_xadverse effects
650 0 4 _aDisease Susceptibility
650 0 4 _aFemale
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aMultidrug Resistance-Associated Proteins
_xgenetics
650 0 4 _aOrganoplatinum Compounds
_xadverse effects
650 0 4 _aOxaliplatin
650 0 4 _aPaclitaxel
_xadverse effects
650 0 4 _aPeripheral Nervous System Diseases
_xchemically induced
650 0 4 _aPolymorphism, Single Nucleotide
700 1 _aOrtiz-Morales, María José
700 1 _aGómez-España, María Auxiliadora
700 1 _aAranda Aguilar, Enrique
773 0 _tMedicina clinica
_gvol. 138
_gno. 10
_gp. 456-7
856 4 0 _uhttps://doi.org/10.1016/j.medcli.2011.07.014
_zAvailable from publisher's website
999 _c21216677
_d21216677